Khalid Ibrahim, D., دعاء, Akram Yahya, N. and نورالهدى 2023. Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor. Iraqi Journal of Pharmacy. 20, 2 (Dec. 2023), 168–173.